Curcumin-mediated reversal of p15 gene promoter methylation: Implication in anti-neoplastic action against acute lymphoid leukaemia cell line

Folia Biologica (Czech Republic)

Volumn 61, Issue 2, 2015, Pages 80-89

  Sharma, V ^a   Jha, A K ^a   Kumar, A ^a   Bhatnagar, A ^a   Narayan, G ^b   Kaur, J ^a  

^a PANJAB UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Apoptosis; Cell cycle; Curcumin; DNA methyltransferase 1

Indexed keywords

CURCUMIN; DNA METHYLTRANSFERASE 1; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; CDKN2B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; TUMOR PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DEMETHYLATION; DNA FRAGMENTATION ASSAY; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; DRUG CYTOTOXICITY; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MTT ASSAY; P15 GENE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; RAJI CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BIOSYNTHESIS; CELL CYCLE; CHROMOSOME BREAKAGE; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CHROMOSOME BREAKAGE; CURCUMIN; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INDUCTION; GENE EXPRESSION REGULATION, LEUKEMIC; GENOMIC INSTABILITY; HUMANS; NEOPLASM PROTEINS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES;

EID: 84930726122     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Aggarwal, B. B., Kumar, A., Bharti, A. C. (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363-398.
2. Andreoli, F., Barbosa, A. J., Parenti, M. D., Del Rio, A. (2013) Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives. Curr. Pharm. Des. 19, 578-613.
3. Antunes, L. M., Araújo, M. C., Dias, F. L., Takahashi, C. S. (1999) Modulatory effects of curcumin on the chromosomal damage induced by doxorubicin in Chinese hamster ovary cells. Teratog. Carcinog. Mutagen. 19, 1-8.
4. Cameron, E. E., Baylin, S. B., Herman, J. G. (1999) p15INK4B CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94, 2445-2451.
5. Chen, S. S., Raval, A., Johnson A. J., Hertlein, E., Liu, T. H., Jin, V. X. (2009) Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 106, 13433-13438.
6. Chim, C. S., Wong, A. S., Kwong, Y. L. (2003) Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Ann. Hematol. 82, 738-742.
7. Christman, J. (2002) 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21, 5483-5495.
8. Gong, J., Traganos, F., Darzynkiewicz, Z. (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218, 314-319.
9. Gronbaek, K., Nedergaard, T., Andersen, M. K., thor Straten, P., Guldberg, P., Møller, P., Zeuthen, J., Ebbe Hansen, N., Hou-Jensen, K., Ralfkiaer, E. (1998) Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb. Leukemia 12, 1266-1271.
10. Heckenkamp, J., Leszczynski, D., Schiereck, J., Kung, J., LaMuraglia, G. M. (1999) Different effects of photodynamic therapy and γ-irradiation on vascular smooth muscle cells and matrix: implications for inhibiting restenosis. Arterioscler. Thromb. Vasc. Biol. 19, 2154-2161.
11. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-9826.
12. Herman, J. G., Civin, C. I., Issa, J. P., Collector, M. I., Sharkis, S. J., Baylin, S. B. (1997) Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of haematological malignancies. Cancer Res. 57, 837-841.
13. Heyer, G., Saba, S., Adamo, R., Rush, W., Soong, G., Cheung, A., Prince, A. (2002) Staphylococcus aureus agr and sara functions are required for invasive infection but not inflammatory responses in the lung. Infect. Immun. 70, 127-133.
14. Jha, A. K., Nikbakht, M., Parashar, G., Shrivastava, A., Capalash, N., Kaur J. (2010) Reversal of hypermethylation and reactivation of the RARβ2 gene by natural compounds in cervical cancer cell lines. Folia Biol. (Praha) 56, 195-200.
15. Krishan, A. (1975) Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell. Biol. 66, 188-193.
16. Lee, W. J., Shim, J. Y., Zhu, B. T. (2005) Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 68, 1018-1030.
17. Loriot, A., De Plaen, E., Boon, T., De Smet, C. (2006) Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells. J. Biol. Chem. 281, 10118-10126.
18. Melki, J. R., Warnecke, P., Vincent, P. C., Clark, S. J. (1998) Increased DNA methyltransferase expression in leukaemia. Leukemia 12, 311-316.
19. Minami, K., Chano, T., Kawakami, T. (2010) DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma. Clin. Cancer Res. 16, 2751-2759.
20. Mizuno, S., Chijiwa, T., Okamura, T., Akashi, K., Fukumaki, Y., Niho, Y. (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97, 1172-1179.
21. Palle, J., Frost, B. M., Forestier, E., Gustafsson, G., Nygren, P., Hellebostad, M., Jonsson, O. G., Kanerva, J., Schmiegelow, K., Larsson, R., Lönnerholm, G., (2005). Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. Br. J. Haematol. 129, 189-198.
22. Reuter, S., Gupta, S. C., Park, B., Goel, A., Aggarwal, B. B. (2011) Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 6, 93-108.
23. Sanchez, Y., Simo, G. P., Calvin, E., Blas, E. D., Aller, P. (2010) Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. J. Pharmacol. Exp. Ther. 335, 114-123.
24. Simon, H. U., Haj-Yehia, A., Levi-Schaffer, F. (2000) Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418.
25. Stone, S., Dayananth, P., Jiang, P., Weaver-Feldhaus, J. M., Tavtigian, S. V., Cannon-Albright, L. (1995) Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene 11, 987-991.
26. Sun, C., Liu, X., Chen, Y., Liu, F (2005) Anticancer effect of curcumin on human B cell non-Hodgkin's lymphoma. J. Huazhong Univ. Sci. Technolog. Med. Sci. 25, 404-407.
27. Wajed, S. A., Laird, P. W., De Meester, T. R. (2001) DNA methylation: an alternative pathway to cancer. Ann. Surg. 234, 10-20.
28. Wong, I. H., Ng, M. H., Lee, J. C., Lo, K. W., Chung, Y. F., Huang, D. P. (1998) Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation. Br. J. Haematol. 103, 168-175.
29. Wong, I. H., Lo, Y. M., Yeo, W., Lau, W. Y., Johnson, P. J. (2000) Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin. Cancer Res. 6, 3516-3521.
30. Yu, J., Peng, Y., Wu, L. C., Xie, Z., Deng, Y., Hughes, T., He, S., Mo, X. K., Chiu, M., Wang, Q. E., He, X., Shujun Liu, S., Grever, M. R., Liu, Z. (2013) Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS One 8, e55934
31. Zhang, S. J., Endo, S., Ichikawa, T., Washiyama, K., Kumanishi, T (1998) Frequent deletion and 5′CpG island methylation of the p16 gene in primary malignant lymphoma of the brain. Cancer Res. 58, 1231-1237.
32. Zhang, Y. J., Wu, H. C., Shen, J., Ahsan, H., Tsai, W. Y., Yang, H. I. (2007) Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin. Cancer Res. 13, 2378-2384.
33. Zhongfa, L, Zhiliang, X., William, J., Ryan, E. P., Shujun, L., Jianhua, Y., Pui-kai, L., Jiayuh, L., Jame, R. F., Marcucci, G. M., Chenglong, L., Chan, K. K. (2009) Curcumin is a potent DNA hypomethylation agent. Bioorg. Med. Chem. Lett. 19, 706-709.
34. Zwaan, C. M., Kaspers, G. J., Pieters, R., Ramakers-Van Woerden, N. L, den Boer, M. L., Wünsche, R., Rottier, M. M., Hählen, K., van Wering, E. R., Janka-Schaub, G. E., Creutzig, U., Veerman, A. J. (2000) Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood 96, 2879-2886.